chr5-138930857-G-A
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1
The ENST00000302763.12(CTNNA1):c.2220G>A(p.Ser740=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.29 in 1,610,028 control chromosomes in the GnomAD database, including 70,975 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. S740S) has been classified as Likely benign.
Frequency
Consequence
ENST00000302763.12 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CTNNA1 | NM_001903.5 | c.2220G>A | p.Ser740= | synonymous_variant | 16/18 | ENST00000302763.12 | NP_001894.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CTNNA1 | ENST00000302763.12 | c.2220G>A | p.Ser740= | synonymous_variant | 16/18 | 1 | NM_001903.5 | ENSP00000304669 | P1 |
Frequencies
GnomAD3 genomes AF: 0.314 AC: 47726AN: 151918Hom.: 7835 Cov.: 32
GnomAD3 exomes AF: 0.274 AC: 68952AN: 251416Hom.: 10445 AF XY: 0.273 AC XY: 37033AN XY: 135894
GnomAD4 exome AF: 0.287 AC: 418876AN: 1457992Hom.: 63122 Cov.: 31 AF XY: 0.288 AC XY: 208685AN XY: 725582
GnomAD4 genome AF: 0.314 AC: 47784AN: 152036Hom.: 7853 Cov.: 32 AF XY: 0.309 AC XY: 22995AN XY: 74328
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 22, 2018 | - - |
Hereditary cancer-predisposing syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 08, 2018 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Patterned macular dystrophy 2 Benign:1
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Nov 30, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at